SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT ON FORM 8-K
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: December 8, 1997
(Date of earliest event reported)
*******************************
MEDIZONE CANADA LIMITED
(Exact name of Registrant as specified in its charter)
Utah 33-16757-D 87-0431771
- ---- ---------- ----------
State of Commission IRS Taxpayer
Incorporation Registration No. I.D. Number
4505 South Wasatch Boulevard, Suite 210,
Salt Lake City, Utah 84124
Address of Principal executive offices
Registrant's telephone number: (801) 274-8400
<PAGE>
Item 5. Other Events.
------------
On December 8, 1997, the Board of Directors of Medizone Canada Limited (the
Registrant") appointed Milton G. Adair to the Board, replacing Dr. Joseph S.
Latino, who had resigned in July 1997. Thereafter, John D. Pealer resigned from
the Board of Directors, which thereupon appointed Edwin J. Marshall as a
Director. On January 5, 1998, following the resignation of George Handel as a
Director, Dr. Gerard Sunnen was appointed as a Director of the Registrant. Each
of Messrs. Marshall and Adair and Dr. Sunnen are Directors of the Registrant's
parent, Medizone International, Inc., with Mr. Marshall serving as Chairman.
Contemporaneously with these events, Milton J. Adair was named the President and
Chief Executive Officer of the Registrant.
Item 6. Resignation of Registrant's Directors.
-------------------------------------
John D. Pealer and George Handel resigned as Directors of the Registrant on
December 8, 1997 and January 5, 1998, respectively.
2
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Act of 1934, the Registrant
has duly caused this Current Report to be signed on its behalf by the
undersigned, one of its officers thereunto duly authorized.
Dated: New York, New York
January 29, 1998
MEDIZONE CANADA LIMITED
By: s/Milton G. Adair
-------------------
Milton G. Adair
President
